Medicine and Dentistry
Angiotensin Receptor
33%
Anthracycline
66%
Beta Adrenergic Receptor Blocking Agent
42%
Breast Cancer
17%
Candesartan
17%
Cardiac Magnetic Resonance Imaging
8%
Cardiac Troponin
42%
Cardiotoxicity
66%
Carvedilol
17%
Chronic Lung Disease
5%
Disease Course
16%
Dyspnea
5%
Heart Left Ventricle Ejection Fraction
42%
Heart Left Ventricle Failure
18%
Heart Muscle Injury
9%
Heart Protection
16%
Infection
5%
Interstitial Lung Disease
66%
Lung
5%
Non-Hodgkin Lymphoma
8%
Oxygen Consumption
5%
Patient-Reported Outcome
5%
Pediatrics
5%
Pulmonary Disorder
5%
Quality of Life
11%
Randomized Controlled Trial
33%
Receptor Blocking
33%
Renin-Angiotensin System Inhibitor
13%
Troponin
33%
Troponin I
42%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin Receptor
33%
Anthracycline
100%
Beta Adrenergic Receptor Blocking Agent
42%
Breast Cancer
28%
Candesartan
17%
Cardiotoxicity
77%
Carvedilol
17%
Chemotherapy
73%
Cohort Study
5%
Epirubicin
11%
Heart Left Ventricle Failure
18%
Heart Muscle Injury
20%
Iatrogenic Disease
5%
Malignant Neoplasm
5%
Nonhodgkin Lymphoma
8%
Randomized Controlled Trial
33%
Renin-Angiotensin System Inhibitor
13%
Troponin
62%
Troponin I
76%
Nursing and Health Professions
Angiotensin Receptor
33%
Anthracycline
33%
Blood Sampling
11%
Breast Cancer
11%
Cancer Therapy
5%
Candesartan
9%
Cardiotoxicity
11%
Cohort Analysis
5%
Epirubicin
11%
Female Patient
5%
Heart Muscle Injury
11%
Iatrogenesis
5%
Malignant Neoplasm
5%
Receptor Blocking
33%
Troponin
16%
Troponin I
33%
